Jiuxiang Li
Sales & Marketing chez China Nuokang Bio-Pharmaceutical, Inc.
Profil
Jiuxiang Li is currently the Director-Marketing at China Nuokang Bio-Pharmaceutical, Inc. He previously worked as a Manager at Shenyang Shuangding Pharmaceutical Co., Ltd.
Dr. Li holds a doctorate degree from Shenyang Pharmaceutical University, a graduate degree from Dalian University, and an undergraduate degree from Shenyang Medicine College.
Postes actifs de Jiuxiang Li
| Sociétés | Poste | Début |
|---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
 China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Sales & Marketing | 23/11/2009 |
Anciens postes connus de Jiuxiang Li
| Sociétés | Poste | Fin |
|---|---|---|
| Shenyang Shuangding Pharmaceutical Co., Ltd. | Corporate Officer/Principal | 01/12/2003 |
Formation de Jiuxiang Li
| Dalian University | Graduate Degree |
| Shenyang Pharmaceutical University | Doctorate Degree |
| Shenyang Medicine College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
| Shenyang Shuangding Pharmaceutical Co., Ltd. |
